Prescription drug · ANDA
Glycopyrrolate NDC 68094-073
Glycopyrrolate 1 mg/5mL · Solution · Oral · Precision Dose, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68094-073-58 | 68094007358 | 50 BAG in 1 CASE (68094-073-58) / 1 SYRINGE, PLASTIC in 1 BAG / 5 mL in 1 SYRINGE, PLASTIC (68094-073-01)Marketed from Jul 7, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Glycopyrrolate
- Generic name (nonproprietary)
- glycopyrrolate
- Active ingredients
- Glycopyrrolate — 1 mg/5mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Precision Dose, Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204438
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Antagonists (Mechanism)Cholinergic Muscarinic Antagonists (Mechanism)
- Identifiers
- Product ID 68094-073_0a84301a-febc-4552-97d6-1fd16f191545SPL ID 0a84301a-febc-4552-97d6-1fd16f191545SPL set ID e58f860b-e955-4d71-a128-93bd3812b08dRxCUI 999961UNII V92SO9WP2I
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468094007358followed by a unit qualifier and the quantityPackage 68094-0073-58. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Glycopyrrolate oral solution is indicated to reduce chronic severe drooling in patients aged 3 to 16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). Glycopyrrolate oral solution is an anticholinergic indicated to reduce chronic severe drooling in patients aged 3 to16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 204438
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | Bryant Ranch Prepack | 63629-9592 |
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | Par Health USA, LLC | 49884-042 |